SafeCode Drug Technologies Corp. (fka SAFC)

[JoeMonte1]

Here you go: Thank Jerry for this.


On November 15, 2012, Medisafe 1 Technologies Corp., a Delaware corporation (the "Registrant" or "Medisafe"), entered into a license agreement (the "License Agreement") with Safecode Drug Technologies Corp., a Delaware corporation and a public reporting company engaged in the medical technology business ("Safecode"). Pursuant to the License Agreement, Medisafe, as licensor, granted Safecode, as licensee, a non - exclusive license to manufacture, market and otherwise commercially exploit world-wide Medisafe's patented device for administering medicine in correct dosages to the correct patients. The License Agreement provides that as consideration for the license, Safecode will issue to Medisafe ten million shares of its common stock valued at $.70 per share. the License Agreement provides for certain adjustments in the event that Safecode's shares are not equal to or greater than that price twelve months after the effective date. The License Agreement is attached hereto as Exhibit 99.1.